Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE is a quinoxaline derivative that features a diol and diium group. 2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE is distinguished by the presence of ethoxycarbonyl and methyl groups, which may enhance its biological activity. It has been the subject of research for its potential applications in various fields, including pharmaceuticals, due to the broad spectrum of properties exhibited by quinoxaline compounds, such as anticancer, antiviral, and antimicrobial activities.

13297-18-2

Post Buying Request

13297-18-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13297-18-2 Usage

Uses

Used in Pharmaceutical Industry:
2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE is used as a potential therapeutic agent for its possible anticancer properties. 2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE's structure, including the ethoxycarbonyl and methyl groups, may contribute to its effectiveness against cancer cells, although further research is required to confirm these effects and optimize its use in cancer treatment.
Used in Antiviral Applications:
In the field of antiviral research, 2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE is considered for its potential to inhibit viral replication and infection. 2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE's specific structural features might allow it to interfere with viral processes, providing a new avenue for antiviral drug development.
Used in Antimicrobial Applications:
2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE is also being explored for its potential antimicrobial capabilities. Given the increasing prevalence of antibiotic-resistant bacteria, 2-(ETHOXYCARBONYL)-3-METHYLQUINOXALINEDIIUM-1,4-DIOLATE could offer a new approach to combat resistant strains if its antimicrobial properties are substantiated through further research.

Check Digit Verification of cas no

The CAS Registry Mumber 13297-18-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,9 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13297-18:
(7*1)+(6*3)+(5*2)+(4*9)+(3*7)+(2*1)+(1*8)=102
102 % 10 = 2
So 13297-18-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O4/c1-3-18-12(15)11-8(2)13(16)9-6-4-5-7-10(9)14(11)17/h4-7H,3H2,1-2H3

13297-18-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-carboxylate

1.2 Other means of identification

Product number -
Other names 2-ethoxycarbonyl-3-methylquinoxaline di-N-oxide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13297-18-2 SDS

13297-18-2Relevant articles and documents

Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents

Jaso, Andrés,Zarranz, Belén,Aldana, Ignacio,Monge, Antonio

, p. 2019 - 2025 (2005)

Twenty-nine new 6(7)-substituted quinoxaline-2-carboxylate 1,4-dioxide derivatives were synthesized and evaluated for in vitro antituberculosis activity. In general, the in vitro activity is significantly affected by substituents on the quinoxaline nucleu

The enthalpies of dissociation of the N-O bonds in two quinoxaline derivatives

Gomes, Jose R. B.,Monteiro, Andre R.,Campos, Bruno B.,Gomes, Paula,Ribeiro Da Silva, Maria D. M. C.

, p. 17 - 23 (2009)

The present work reports the first experimental thermochemical study of mono-N-oxides derived from quinoxaline, namely, 3-methoxycarbonyl-2-methyl- quinoxaline N-oxide and 3-ethoxycarbonyl-2-methyI-quinoxaIine N-oxide. The values of the enthalpies of formation, in the condensed state, and of the enthalpies of sublimation, derived from static bomb calorimetry and Calvet microcalorimetry measurements, respectively, are combined to derive the standard molar enthalpies of formation in the gaseous phase for these two compounds. From the latter values, the first and second N-O bond dissociation enthalpies for the corresponding di-N-oxides have been obtained. The gas-phase experimental results are also compared with calculated data obtained with a density functional theory approach. Copyright

SYNTHESIS, CRYSTAL AND MOLECULAR STRUCTURES OF 2-METHYL-3-CARBOETHOXYQUINOXALINE 1,4-DIOXIDE

Lin, Shu-Kun,Cong, Qiu-Zhi

, p. 279 - 286 (1987)

2-Methyl-3-carboethoxyquinoxaline 1,4-dioxide (MCQO) was prepered and single crystals were grown out of the reaction mixture.The structure of MCQO was established by single-crystal X-ray crystallography using a direct method.The crystals are triclinic, space group P, with a = 6.928(1), b = 8.109(1), c = 10.552(1) angstroem, α = 83.445(8), β = 85.681(10), γ = 79.168(8) deg, V = 577.7 angstroem3, Z = 2 and Dc = 1.428 g cm-3.The structure was refined to R = 0.059 for 1454 reflections.The planar geometry of the parent quinoxaline ring is consistent with the aromaticity of the condensed heterocyclic system in the compound.The average N-O bond length is 1.297(5) angstroem, indicating a certain double-bond character.The X-ray analysis corroborates IR, NMR, and ESR spectroscopic evidence for the structure of this type of heteroaromatic N-oxides.

Tandem C-N Bond Formation through Condensation and Metal-Free N-Arylation: Protocol for Synthesizing Diverse Functionalized Quinoxalines

Jiao, Yan-Xiao,Wu, Ling-Ling,Zhu, Hai-Miao,Qin, Jiang-Ke,Pan, Cheng-Xue,Mo, Dong-Liang,Su, Gui-Fa

, p. 4407 - 4414 (2017/04/28)

Diverse functionalized quinoxalines were synthesized in good yields from arylamines and readily available β-keto oximes through condensation and metal-free N-arylation. The reaction was compatible with various functional groups, such as halides, cyano, and esters. A mechanism was proposed based on the experimental results. These quinoxalines were easily obtained on a gram scale and converted to various useful scaffolds. Compound LASSBio-1022 was prepared in 83% yield in two steps.

Combining metabolite-based pharmacophores with Bayesian machine learning models for mycobacterium tuberculosis drug discovery

Ekins, Sean,Madrid, Peter B.,Sarker, Malabika,Li, Shao-Gang,Mittal, Nisha,Kumar, Pradeep,Wang, Xin,Stratton, Thomas P.,Zimmerman, Matthew,Talcott, Carolyn,Bourbon, Pauline,Travers, Mike,Yadav, Maneesh,Freundlich, Joel S.

, (2015/12/26)

Integrated computational approaches for Mycobacterium tuberculosis (Mtb) are useful to identify new molecules that could lead to future tuberculosis (TB) drugs. Our approach uses information derived from the TBCyc pathway and genome database, the Collabor

Synthesis and UV absorption of new conjugated quinoxaline 1,4-dioxide derivatives anticipated as tumor imaging and cytotoxic agents

El-Gogary, Sameh R.,Waly, Mohamed A.,Ibrahim, Ismail T.,El-Sepelgy, Osama Z.

experimental part, p. 1253 - 1262 (2011/08/08)

New conjugated arylidine, enamine, and annelated pyrido derivatives of quinoxaline 1,4-dioxide were synthesized via utilization of an active allylic methyl group. Biodistribution studies were carried out by injecting a solution of an 125I deriv

Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates

Romeiro, Nelilma C.,Aguirre, Gabriela,Hernandez, Paola,Gonzalez, Mercedes,Cerecetto, Hugo,Aldana, Ignacio,Perez-Silanes, Silvia,Monge, Antonio,Barreiro, Eliezer J.,Lima, Lidia M.

experimental part, p. 641 - 652 (2009/08/07)

In this paper, we report the structural design, synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazone (NAH) derivatives, planned as cruzain inhibitors candidates, a cysteine protease essential for the survival of Trypan

Synthesis of the possible metabolites of quinocetone in animals

Li, Jian-Yong,Zhang, Ji-Yu,Zhou, Xu-Zheng,Li, Jin-Shan,Lu, Run-Hua

, p. 49 - 56 (2008/02/12)

The possible metabolites of quinocetone in animals had been prepared with different selective reagent by three synthetic routes. It was their principal reaction that Na2S2O4 reduced quinoxaline-1,4-dioxide derivatives to quinoxaline derivatives, H 2O2 s oxidized 2-carboxyl-quinoxaline derivatives to 2-carboxyl-quinoxaline-1 -oxide ones and P(OCH3) 3 reduced 2-carboxyl- quinoxaline-1,4-dioxide derivatives to 3-carboxyl-quinoxaline-1-oxide ones. The title compounds ware confirmed with NMR,UV, FAB-MS, et al.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13297-18-2